Medscape reports the finding on nail separation in GLP-1 users. Experts quoted call for more research and caution doctors against alarming patients.
Recap by typeshit. Post by @medscape on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A case study of a 58-year-old knee patient walks through lean mass loss, sarcopenia risk and tendon changes for people on GLP-1 drugs during rehab.
Researchers are working on peptides that can withstand the gut and target specific cells. That could open a path to more precise prescription pills.
Loading…